Trial results for a study investigating strategies for effective debridement in patients with Venous Leg Ulcers were posted on ClinicalTrials.gov on 2026-05-14, indicating that wound edge debridement resulted in a 62.5% healing rate compared to 21.4% with standard care.
Background
Venous Leg Ulcers (VLUs) are chronic, non-healing wounds that represent a significant challenge in wound care. These ulcers often persist for extended periods, leading to pain, reduced quality of life, and substantial healthcare costs. Current treatment approaches typically involve compression therapy and local wound care, but healing rates can vary, and many ulcers remain recalcitrant. The goal of this study was to explore whether guided surgical debridement, informed by genomic profiling, could improve healing outcomes in these difficult-to-treat chronic wounds.
Trial design
This completed study, identified as Phase NA, enrolled 41 participants with Venous Leg Ulcer. The trial aimed to develop strategies for effective debridement by utilizing genomic profiling and candidate genes/proteins to guide surgical debridement. The efficacy of this approach was then tested. Participants were allocated to either a Wound Edge Debridement Group or a Standard Care Group, serving as a comparator. The intervention involved guided surgical debridement.
Key results
The trial reported several key measurements related to genetic changes and healing rates:
- For the outcome titled "Change in the Genetic Profile After Debridement in the Intervention Group," the Wound Edge Debridement Group showed 1031 Number of Differentially Expressed Genes.
- Regarding the "Percent Rate of Healing Versus Non-healing Wounds Within Each Treatment Group":
- In the Wound Edge Debridement Group, the healing rate was 62.5 percentage of participants, while the non-healing rate was 37.5 percentage of participants.
- In the Standard Care Group, the healing rate was 21.4 percentage of participants, while the non-healing rate was 78.6 percentage of participants.
What this means
The posted results suggest that guided surgical debridement may offer a more effective strategy for improving healing in chronic Venous Leg Ulcers compared to standard care. The observed healing rate of 62.5% in the debridement group, significantly higher than the 21.4% in the standard care group, indicates a potential clinical benefit. Furthermore, the change in the genetic profile, with 1031 differentially expressed genes after debridement, points to a biological impact of the intervention. These findings could inform future approaches to VLU management, potentially leading to better outcomes for patients suffering from these persistent wounds.
Source
The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT03796793, titled "Developing Strategies for Effective Debridement in Patients for Venous Leg Ulcers," were posted on 2026-05-14 on clinicaltrials.gov.